๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase I trial of combined therapy with bleomycin and the calmodulin antagonist, trifluoperazine

โœ Scribed by William N. Hait; Steve Morris; John S. Lazo; Robert J. Figlin; Henry J. Durivage; Kathleen White; Peter E. Schwartz


Publisher
Springer
Year
1989
Tongue
English
Weight
580 KB
Volume
23
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Phase-I trial of combination therapy wit
โœ William P. Peters; Geoffrey Weiss; Donald W. Kufe ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› Springer ๐ŸŒ English โš– 301 KB

Fourty-four evaluable patients were treated with 6-methylmercaptopurine riboside (MMPR) at a dose of 20 mg/m2/day X 5 by continuous IV infusion (days 1-5 and 5-fluorouracil (5-FU) on an escalating dose schedule of 300-1519 mg/m2/day X 5 by continuous IV infusion (days 2-6). Dose-limiting oral mucosi